Climb Bio (CLYM)
NASDAQ:CLYM
US Market
Holding CLYM?
Track your performance easily

Climb Bio (CLYM) Financial Statements

48 Followers

Climb Bio Financial Overview

Climb Bio's market cap is currently ―. The company's EPS TTM is $-2.148; its P/E ratio is -1.64; Climb Bio is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 33.00K----
Gross Profit$ 33.00K----
EBIT$ -54.89M$ -3.00M$ -5.00M$ -5.22M$ -23.44M
EBITDA$ -54.89M$ -3.00M$ -5.00M$ -5.22M$ -23.44M
Net Income Common Stockholders$ -54.89M$ -1.70M$ -3.97M$ -5.22M$ -22.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 223.14M$ 105.00M$ 107.43M$ 102.63M$ 109.37M
Total Assets$ 226.02M$ 109.33M$ 112.73M$ 116.27M$ 122.08M
Total Debt$ 100.00K$ 225.00K$ 459.00K$ 585.00K$ 687.00K
Net Debt$ -223.04M$ -104.78M$ -106.97M$ -102.05M$ -108.69M
Total Liabilities$ 3.74M$ 2.95M$ 2.99M$ 3.77M$ 5.22M
Stockholders Equity$ 222.28M$ 106.36M$ 109.74M$ 112.50M$ 116.81M
Cash Flow-
Free Cash Flow$ -5.31M$ -1.82M$ 3.49M$ -7.96M$ -15.18M
Operating Cash Flow$ -667.00K$ -1.82M$ 3.49M$ -7.96M$ -15.18M
Investing Cash Flow$ -9.64M$ 13.75M$ 28.04M$ -1.60M$ 5.80M
Financing Cash Flow$ 128.40M$ 15.00K$ 528.00K$ 24.00K$ 1.00K
Currency in USD

Climb Bio Earnings and Revenue History

Climb Bio Debt to Assets

Climb Bio Cash Flow

Climb Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis